Azemiglitazone Uses, Dosage, Side Effects and more
Azemiglitazone is under investigation in clinical trial NCT01280695 (A Randomized, Double-blind, Comparator- and Placebo-controlled, Multiple-dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients).
| Attribute | Details |
|---|---|
| Trade Name | Azemiglitazone |
| Generic | Azemiglitazone |
| Azemiglitazone Other Names | Azemiglitazone |
| Type | |
| Formula | C19H17NO5S |
| Weight | Average: 371.41 Monoisotopic: 371.082743825 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
